Series A · Healthtech · Sucy-en-Brie, France · Founded 2023 · 11–50 employees
Biolevate is a deeptech health-AI startup developing an enterprise-grade agentic AI platform for regulated life sciences operations. The software automates complex scientific, clinical, and regulatory workflows, including systematic literature reviews, batch record quality control, medical writing, and regulatory dossier bridging. The platform generates auditable, evidence-grounded outputs while maintaining essential human oversight. The company reached approximately 50 employees following a landmark €30 million Series A funding round in September 2026. Selected for the Station F Future 40 and French Tech 2030 programs, Biolevate supports biopharma clients across Europe and the United States from its dual bases in France and Boston.
No open roles listed right now.